Citation Impact
Citing Papers
Acute Phase Proteins with Special Reference to C-Reactive Protein and Related Proteins (Pentaxins) and Serum Amyloid A Protein
1983 Standout
Sex hormones and skin collagen content in postmenopausal women.
1983
Comparative clinical study of protein SAP (amyloid P component) and C-reactive protein in serum.
1978
SERUM C‐REACTIVE PROTEIN LEVELS IN DISEASE*
1982
A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving Methotrexate
1999 Standout
Rheumatoid arthritis
2016 Standout
Complications resulting from the use of chinese herbal medications containing undeclared prescription drugs
1995
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis1
2002
Herb-drug interactions
2000 Standout
Paradoxical inhibition of cardiac lipid peroxidation in cancer patients treated with doxorubicin. Pharmacologic and molecular reappraisal of anthracycline cardiotoxicity.
1996
Plain X-rays in rheumatoid arthritis: overview of scoring methods, their reliability and applicability
1996
Juvenile idiopathic arthritis
2007 Standout
Estrogen and Skin
2001
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
2003 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Modulation of oxidative stress as an anticancer strategy
2013 Standout
Drug-Induced Hepatotoxicity
2003 Standout
C-reactive protein: a critical update
2003 Standout
The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials
1993 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris
1995 Standout
Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis
2004 Standout
Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
1992 Standout
The role of reactive oxygen species in homeostasis and degradation of cartilage
2003
Sulfasalazine in the treatment of juvenile chronic arthritis: A randomized, double-blind, placebo-controlled, multicenter study
1998
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Oral Therapy forPneumocystis cariniiPneumonia in the Acquired Immunodeficiency Syndrome
1990
The development of androgen-independent prostate cancer
2001 Standout
The effects of drug therapy on radiographic progression of rheumatoid arthritis. results of a 36‐week randomized trial comparing methotrexate and auranofin
1993
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
2014 Standout
The antioxidant role of bile pigments evaluated by chemical tests
1994
Analysis of Missed Cases of Abusive Head Trauma
1999 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Sulfasalazine in the treatment of spondylarthropathy
1995
Corticosteroids in rheumatoid arthritis
1989
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
2001 Standout
Association of Fibrinogen, C-reactive Protein, Albumin, or Leukocyte Count With Coronary Heart Disease
1998 Standout
Inflammatory Bowel Disease
1991 Standout
Wegener Granulomatosis: An Analysis of 158 Patients
1992 Standout
A facile and versatile preparation of bilindiones and biladienones from tetraarylporphyrins
2005 StandoutNobel
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
2000 Standout
Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial
1999
Ankylosing spondylitis
2007 Standout
Radiographic outcome of recent-onset rheumatoid arthritis: A 19-year study of radiographic progression
1998
C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease
2004 Standout
Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs
1991 Standout
Periodontitis: from microbial immune subversion to systemic inflammation
2014 Standout
The three-dimensional structure of α1-purothionin in solution: combined use of nuclear magnetic resonance, distance geometry and restrained molecular dynamics
1986 StandoutNobel
Tamoxifen in the Treatment of Breast Cancer
1998
A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
2000 Standout
Severe Adverse Cutaneous Reactions to Drugs
1994 Standout
Rheumatoid arthritis
2010 Standout
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
2012 Standout
Proposal for a new nomenclature of disease-modifying antirheumatic drugs
2013
Targeting ferroptosis as a vulnerability in cancer
2022 Standout
Estrogen and Skin
2011
The progression of erosion and joint space narrowing scores in rheumatoid arthritis during the first twenty‐five years of disease
1991
Acute-Phase Proteins and Other Systemic Responses to Inflammation
1999 Standout
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
1994 Standout
Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures.
1995 Standout
Association between chronic periodontitis and rheumatoid arthritis: a hospital-based case–control study
2012
Radiographic outcome after three years of patients with early erosive rheumatoid arthritis treated with intramuscular methotrexate or parenteral gold. Extension of a one‐year double‐blind study in 174 patients
2002
NONSTEROIDAL ANTI-INFLAMMATORY DRUGS ANOTHER LOOK
1988
Reassessment of Twelve Traditional Paradigms Concerning the Diagnosis, Prevalence, Morbidity and Mortality of Rheumatoid Arthritis
1989
Nrf2 activation improves experimental rheumatoid arthritis
2023 StandoutNobel
Lymphocytes binding C-reactive protein during acute rheumatic fever.
1978
An Epidemiologic Study of Cervical and Trochanteric Fractures of the Femur in an Urban Population Analysis of 1,664 Cases with Special Reference to Etiologic Factors
1964
Gold colitis induced by auranofin treatment of rheumatoid arthritis: case report and review of the literature.
1987
Sulfasalazine
2005
Polymyositis and Dermatomyositis
1975 Standout
Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis.
1992
C-reactive protein for rapid diagnosis of infection in leukaemia.
1979
Association of estrogen replacement therapy with the risk of osteoarthritis of the hip in elderly white women. Study of Osteoporotic Fractures Research Group.
1996
1 Immunopharmacology of Gold
1982
Value of serum C-reactive protein measurement in the investigation of fever in systemic lupus erythematosus.
1980
Recent Advances in Transition Metal Catalyzed Oxidation of Organic Substrates with Molecular Oxygen
2005 Standout
Role of T lymphocytes in murine collagen induced arthritis
1986
A double‐blind, placebo‐controlled trial
1986
Excretion of pyridinium crosslinks correlates with disease activity and appendicular bone loss in early rheumatoid arthritis.
1994
Serum levels of C‐reactive protein in Crohn's disease and ulcerative colitis
1982
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
C-Reactive Protein Estimation in Lupus Erythematosus
1980
Acute Phase Reactant Proteins in Cancer
1979
Sulfasalazine for treating rheumatoid arthritis
1998
C-reactive protein, ESR, and klebsiella in ankylosing spondylitis.
1980
C-reactive protein in childhood dermatomyositis
1982
Steroid-Induced Fractures and Bone Loss in Patients with Asthma
1983
Amyloid Deposits and Amyloidosis
1980 Standout
Inflammation and Atherosclerosis
2002 Standout
Direct and metabolism‐dependent toxicity of sulphasalazine and its principal metabolites towards human erythrocytes and leucocytes.
1991
Usage and adverse effects of Chinese herbal medicines
1996
C-REACTIVE PROTEIN FIFTY YEARS ON
1981
Serum beta 2 microglobulin and C-reactive protein in the monitoring of lymphomas findings in a multicenter study and experience in selected patients
1980
Importance of intestinal mucosal immunity and luminal bacterial cell wall polymers in the aetiology of inflammatory joint diseases
1989
Adulteration by Synthetic Therapeutic Substances of Traditional Chinese Medicines in Taiwan
1997
Predictors of acute relapse of Crohn's disease
1987
Muscle Involvement in Sarcoidosis
1969
C‐Reactive Protein in Systemic Lupus Erythematosus
1977
Gold Nanoparticles: A Revival in Precious Metal Administration to Patients
2011 Standout
LONG-TERM OUTCOME OF TREATING RHEUMATOID ARTHRITIS: RESULTS AFTER 20 YEARS
1987
Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.
1992 Standout
Low-dose methotrexate treatment of rheumatoid arthritis. Long-term observations
1985
Osteoarthritis: New Insights. Part 1: The Disease and Its Risk Factors
2000 Standout
Long‐term effects of the menopause and sex hormones on skin thickness
1985
C-reactive protein: a critical update
2003 Standout
An Evaluation of Serum Protein Profiles in the Long-Term Surveillance of Prostatic Cancer
1980
Activation of methane by oxygen and nitrogen oxides
2002
C‐reactive protein levels in systemic lupus erythematosus: a classification criterion?
1980
Solid phase radioimmunoassays for human C-reactive protein
1981
Works of B McConkey being referenced
Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.
1983
Chuei-Fong-Tou-Geu-Wan in rheumatoid arthritis.
1979
Sulphasalazine in rheumatoid arthritis.
1980
Rheumatoid arthritis: C-reactive protein and erythrocyte sedimentation rate during initial treatment.
1978
What should we hope to achieve when treating rheumatoid arthritis?
1989
Rheumatoid arthritis: the effects of treatment with dapsone on hemoglobin.
1984
OSTEOPOROSIS AND PURPURA IN RHEUMATOID DISEASE: PREVALENCE AND RELATION TO TREATMENT WITH CORTICOSTEROIDS
1962
Effects of gold, dapsone, and prednisone on serum C-reactive protein and haptoglobin and the erythrocyte sedimentation rate in rheumatoid arthritis.
1979
Relationship between erythrocyte sedimentation rate and serum C-reactive protein in rheumatoid arthritis.
1979
High-dose intravenous methylprednisolone in rheumatoid arthritis.
1982
Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years.
1986
NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND RENAL FAILURE
1986
The Effects of Some Anti-inflammatory Drugs on the Acute-phase Proteins in Rheumatoid Arthritis
1973
Outcome of attempts to treat rheumatoid arthritis with gold, penicillamine, sulphasalazine, or dapsone.
1984
Long-term treatment of rheumatoid arthritis with sulphasalazine, gold, or penicillamine: a comparison using life-table methods.
1987
TRANSPARENT SKIN AND OSTEOPOROSIS
1963
Measurement of Conjugated Diene Lipids by Derivative Spectroscopy in Heptane Extracts of Plasma
1990
The Assessment of Rheumatoid Arthritis<subtitle>A STUDY BASED ON MEASUREMENTS OF THE SERUM ACUTE-PHASE REACTANTS</subtitle>
1972
Transparent Skin and Osteoporosis
1965
Life threatening interaction between tamoxifen and warfarin.
1987
Oxidation of Methane to Formaldehyde in a Fluidized Bed Reactor
1967
Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes.
1977
Significance of the occurrence of transparent skin. A study of histological characteristics and biosynthesis of dermal collagen.
1967
RHEUMATOID ARTHRITIS AND IgA NEPHROPATHY
1987
Does Sulphasalazine Cause Folate Deficiency in Rheumatoid Arthritis?
1985
DRUG TREATMENT OF RHEUMATOID ARTHRITIS
1975
Muscular Dystrophy in Sarcoidosis
1958
Chain breaking antioxidant status in rheumatoid arthritis: clinical and laboratory correlates.
1991